BasePair Amplis Test

A Complete DNA test to Help Guide Your Medication Decisions.

This test determines how your genetic profile effects the way you may respond to various medications. This test aims to lessen the trial and error of prescribing by providing suggested medications that are based on your genetics. The test analyses eighteen genes, covering liver metabolism, as well as drug transporters and receptors.

BasePair Amplis report has been found to be particularly useful for patients taking multiple medications, or those who have had medication failures or experienced significant side-effects, as well as the elderly. It can also be useful even before commencing medication, enabling the right medication selection for you, the first time.

Genes Tested

BasePair Genomics Amplis test, is a genetic test that can determine the metaboliser status of an individual for eighteen genes important for liver metabolism, as well as drug transporters and receptors: ABCB1, ABCC1, ABCG2, CYP1A2, CYP2B6, CYP2C9, CYP2C19, CYP2D6, CYP3A4, CYP3A5, COMT, DPYD, NUDT15, OPRM1, SLCO1B1, TPMT, UGT1A1 VKORC1.